← Back to Patent Explorer
US4035150A Expired / Lapsed US ⏱️ 0.0 years remaining

Test for occult blood in an emulsified aqueous/organic system

Assignee: United States Department of Health and Human Services
•
Filing: 1976-07-07
•
Granted: 1977-07-12
•
Expires: 1996-07-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method and test of detecting occult blood in a stool or other physiologic fluid sample which offers novelty in that the reaction is carried out in the organic phase selected from the group consisting of methylene dichloride, petroleum ether, and dioxane in an aqueous/organic bi-phase system wherein the sample of occult blood is added to the aqueous phase, the bi-phase system is mixed by emulsification and a standard color-forming reaction involving organically soluble hemoglobin (heme), peroxide, and dye is carried out in the organic phase. Optionally, a filter paper porous only to organic solvents may be introduced to initially separate the aqueous and organic phases and further a device for mixing and separating immiscible liquids having two chambers telescopable into one another may be utilized. The reaction involving hemoglobin is carried out in acetic acid to produce heme which is later solubilized by the organic solvent. An advantage over previous tests lies in the effectiveness of the present method even in the presence of normally occurring amounts of ascorbic acid which inhibit all aqueous phase methods. The present test will give positive results for occult blood in the presence of at least 20 mg/dl of ascorbic acid (Vitamin C) or, alternatively, where the patient has ingested levels of Vitamin C or other reducing agent at an input of above 6 gm/day orally. This latter factor is quite important in present-day clinical practice where a substantial percentage of the patients are ingesting Vitamin C.

Inventors

  • 👤 Russell M. Jaffe

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-25 11:38
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/72; G01N33/721; G01N33/726; B; B01; B01D; B01D33/00; B01D33/01; G01N33/725; Y; Y10; Y10S; Y10S436/00; Y10S436/904; Y10T; Y10T436/00; Y10T436/25; Y10T436/25375; Y10T436/255

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 72 words
A method of detecting occult blood in a sample which comprises carrying out the reaction in the organic phase selected from the group consisting of methylene dichloride, petroleum ether, and dioxane of an aqueous/organic bi-phase system wherein a sample of occult blood is added to the aqueous phase, the bi-phase system is emulsified, and a standard color-forming reaction involving solubilized hemoglobin (heme), peroxide, and dye is carried out in the organic phase.
Claim 2
Independent Claim 72 words
A method of detecting occult blood in a sample which comprises carrying out the reaction in the organic phase selected from the group consisting of methylene dichloride, petroleum ether, and dioxane of an aqueous/organic bi-phase system wherein a sample of occult blood is added to the aqueous phase, the bi-phase system is emulsified, and a standard color-forming reaction involving solubilized hemoglobin (heme), peroxide, and dye is carried out in the organic phase.
Claim 3
Dependent Claim 12 words
The method according to claim 1 wherein the sample contains ascorbic acid.
Claim 4
Dependent Claim 17 words
The method according to claim 1 wherein the sample contains at least 20 mg/dl of ascorbic acid.
Claim 5
Independent Claim 117 words
A method of detecting occult blood in a sample which comprises carrying out the detection in an aqueous/organic bi-phase system in which the organic phase is comprised of a solvent selected from the group consisting of methylene dichloride, petroleum ether and dioxane, peroxide and a dye and in which the aqueous phase is comprised of an acid selected from the group consisting of acetic, fumaric, itaconic, maleic, malic, malonic, mandelic, and sulfuric, adding a sample of the occult blood to the aqueous phase whereby blood hemoglobin is hydrolyzed to heme, emulsifying the biphase system to solubilize the heme in the organic phase, oxidize the heme and produce a color change in the presence of the dye reagent.
Claim 6
Independent Claim 117 words
A method of detecting occult blood in a sample which comprises carrying out the detection in an aqueous/organic bi-phase system in which the organic phase is comprised of a solvent selected from the group consisting of methylene dichloride, petroleum ether and dioxane, peroxide and a dye and in which the aqueous phase is comprised of an acid selected from the group consisting of acetic, fumaric, itaconic, maleic, malic, malonic, mandelic, and sulfuric, adding a sample of the occult blood to the aqueous phase whereby blood hemoglobin is hydrolyzed to heme, emulsifying the biphase system to solubilize the heme in the organic phase, oxidize the heme and produce a color change in the presence of the dye reagent.

References Cited (Backward Citations)

US3865548A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-07-11 1981-01-10 1981-07-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-07-11 1985-01-10 1985-07-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-07-11 1989-01-10 1989-07-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag